Taxanes in the Treatment of Advanced Gastric Cancer
AbstractAlthough rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first- or second-line chemotherapy setting for AGC. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Kang, B.W.; Kwon, O.-K.; Chung, H.Y.; Yu, W.; Kim, J.G. Taxanes in the Treatment of Advanced Gastric Cancer. Molecules 2016, 21, 651.
Kang BW, Kwon O-K, Chung HY, Yu W, Kim JG. Taxanes in the Treatment of Advanced Gastric Cancer. Molecules. 2016; 21(5):651.Chicago/Turabian Style
Kang, Byung W.; Kwon, Oh-Kyoung; Chung, Ho Y.; Yu, Wansik; Kim, Jong G. 2016. "Taxanes in the Treatment of Advanced Gastric Cancer." Molecules 21, no. 5: 651.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.